U.S. orphan drug report part two 2018

Exclusivity, Pricing and Treated Populations

This report depicts the developments of orphan drug industry and market in the United States. Among other issues, it focuses on patent exclusivity, pricing, and patient populations. This is the second part of IQVIA's 2018 report on orphan drugs in the United States.
  • Language: English
  • Released: December 2018
Study included in Corporate Account only.
More than 7,500
companies
trust
Statista
Recommended studies and dossiers
Show more
Recent studies and dossiers
You may also be interested in...
Statista is a great source of knowledge, and pretty helpful to manage the daily work.

Christof Baron about Statista CEO, MindShare Germany

Any more questions?

Get in touch with us quickly and easily.
We are happy to help!